Adverse Reactions in a Clinical Trial of Pediatric Patients Aged 12 Years and Older with Obesity WEGOVY was evaluated in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pediatric patients aged 12 years and older with obesity [see Clinical Studies (14.3) ]
Its not due to safety concerns with longer-term use
For someone weighing 100kg, thats 15-25kg, significantly more than the 5-10% typically achieved with diet and exercise alone
The placebo group (who received the same lifestyle advice but no medication) lost only about 2.4% of their weight To put this in context, semaglutide produces about twice the weight loss of older weight-loss medications
Pick up your bottle today and begin transforming fat into energy one capsule at a time
"We're seeing HSA balances grow, and people are still able to ensure that they're growing their account balance over the long term, which makes for a really interesting dichotomy," Uralil says